Angioceutics International LLC is categorized under Noncommercial Research Organizations in Virginia Beach, VA and active since 2011.
Angioceutics International LLC was established in 2011, and today employs 1 to 4, earning Unknown per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 9999900 by the NAICS.
If you are seeking more information, feel free to contact Jorge L Jacot at the company’s single location by writing to 1141 Kings Way Drive, Virginia Beach, Virginia VA 23455 or by phoning (757) 621-6210. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Angioceutics International LLC |
| Contact Person: | Jorge L Jacot |
| Address: | 1141 Kings Way Drive, Virginia Beach, Virginia 23455 |
| Phone Number: | (757) 621-6210 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Research Organizations |
| SIC Code: | 8733 |
| NAICS Code: | 9999900 |
| Share This Business: |
Angioceutics International LLC was started in 2011 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 9999900. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Jorge L Jacot for inquiries that concern Angioceutics International LLC by calling the company number (757) 621-6210, as your correspondence is most welcome. Additionally, the physical location of the single location of Angioceutics International LLC can be found at the coordinates 36.878752,-76.1293 as well as the street address 1141 Kings Way Drive in Virginia Beach, Virginia 23455.
For its online presence, you may visit Angioceutics International LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.